Search by Drug Name or NDC

    NDC 00456-2220-07 Fetzima 20 mg/1 Details

    Fetzima 20 mg/1

    Fetzima is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is LEVOMILNACIPRAN HYDROCHLORIDE.

    Product Information

    NDC 00456-2220
    Product ID 0456-2220_7b3b300a-81f4-4b72-ad88-71e95d182456
    Associated GPIs 58180050107020
    GCN Sequence Number 071495
    GCN Sequence Number Description levomilnacipran HCl CAP SA 24H 20 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 35327
    HICL Sequence Number 040632
    HICL Sequence Number Description LEVOMILNACIPRAN HCL
    Brand/Generic Brand
    Proprietary Name Fetzima
    Proprietary Name Suffix n/a
    Non-Proprietary Name LEVOMILNACIPRAN HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name LEVOMILNACIPRAN HYDROCHLORIDE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204168
    Listing Certified Through 2024-12-31

    Package

    NDC 00456-2220-07 (00456222007)

    NDC Package Code 0456-2220-07
    Billing NDC 00456222007
    Package 40 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2220-07)
    Marketing Start Date 2013-07-25
    NDC Exclude Flag N
    Pricing Information N/A